OPTImizing Malaria And HIV Treatment in a Shifting Landscape in Africa

NCT06967519 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

380

Enrollment

OTHER

Sponsor class

Conditions

Malaria
Hiv

Interventions

DRUG: Artemether-lumefantrine (AL)
DRUG: artesunate-amodiaquine (AS-AQ)

Sponsor

Yale University

Collaborators

[object Object]